This program will prepare pharmacists to enter into a written collaborative practice agreement (CPA) with a supervising physician in accordance with Florida law.

Upon completion of the program the learner will be familiar with the legal and regulatory requirements associated with entering into a collaborative practice agreement, patient assessment and treatments for chronic diseases outlined in Florida law, be able to write a written collaborative practice agreement, and be gain experience building a business model and marketing plan for their practice. For each of the health conditions listed below, the learner will be required to demonstrate the following competencies through interactive completion of live lectures, patient cases, and other active learning exercises:

• Perform needed patient assessment skills
• Develop and communicate plans for ordering, performing, and interpreting clinical and laboratory tests
• Evaluate and develop treatment plans for collaborative practice and communicate these to patients and providers
• List required follow up and documentation for collaborative practice 

Disease States Pharmacists Can Manage in a Collaborative Practice Agreements under Florida Board of Pharmacy Rules and Regulations:

Program Requirements

This program includes a 12-hour fully online, self-paced lecture series and an 8-hour interactive live, online skill-building session. To earn the certificate of achievement the learner will need to successfully meet the requirements outlined below.

• Part 1:  This part of the program is accredited for 12 hours of ACPE continuing education for pharmacists. This self-paced, and fully online educational program that requires the learner to complete a self-study assessment with a passing score of at least 70%.
• Part 2: This part of the program is accredited for 8-hours of ACPE continuing education for pharmacists. This live seminar in which participants discuss patient cases, draft a collaborative practice agreement, and develop a business model and marketing plan for their practice. Learners are actively engaged and receive feedback and direction from faculty experts throughout the program.
• Final assessment: Complete and pass a final assessment that requires the learner to pass with a score of at least 70%.

Acknowledgements and Disclosures

Advisory Board

Department: Entrepreneurial Programs

Kristin Wiisanen Pharm.D., FAPhA, FCCP

Department: Pharmacotherapy & Translational Research

Katie Vogel Anderson Pharm.D., BCACP

Department: Center for Quality Medication Management

Teresa E Roane PharmD, MBA, BCACP

Department: Department of Internal Medicine

Eric Rosenberg M.D., M.S.P.H., F.A.C.P.

Department: MD-CHFM SPRINGHILL

Siegfried O Schmidt MD, PhD

Department: College of Pharmacy Dean's Office

John Gums Pharm.D., FCCP

• Rachel Shaddock, Pharm.D.

Faculty

Department: Pharmacotherapy & Translational Research

Eric A Dietrich Pharm.D., BCACP, CPC-A, CEMC, CPB

Department: Pharmacotherapy & Translational Research

Gary G Cacciatore

Department: Jacksonville Campus

Carol A Motycka Pharm.D., BCACP

Department: Pharmacotherapy & Translational Research

Michelle Z Farland Pharm.D., CDCES

Department: Pharmacotherapy & Translational Research

Eric F Egelund Ph.D., Pharm.D.

Department: MD-PEDIATRICS

Leslie Hendeles Pharm.D.

Refund Policy

The University of Florida College of Pharmacy Office of Continuing Education will utilize fair and equitable policies related to refund, transfer, and extension of courses.

Accommodations for Disabilities or Special Requests

Contact us a minimum of ten working days prior to the conference so that adequate consideration may be given to your request. 

Contact Us

Have a question? We can help!